QVQ
- – Performs Contract Research for industrial partners and academic research groups according to either Service- or Collaboration Agreements.
- – Provides extensive expertise in each step of VHH-development, ranging from immunization, selection and screening to GMP production.
- – Sells high quality VHHs directed against various bacteria, fungi, viruses and human targets in cancer, age related diseases and infectious diseases.
Latest from us
We are pleased to announce that QVQ holding has joined the Biotech Investissement group and is now a sister company of RD-Biotech SAS, Diaclone SAS and SynAbs SA (www.mabexperts.com). RD-Biotech is a Read more
Recently QVQ has decided to invest in Orthros TR, a company that will develop bi-functional VHH to cure Osteoarthritis. This investment follows on the agreement between Orthros TR and QVQ in which Read more
Dr Raimond Heukers studied Laboratory Research in Enschede and Biology of Disease at Utrecht University. He obtained his PhD at Utrecht University with his thesis entitled ‘Clustering-Induced, Clathrin-Mediated Endocytosis for cancer therapy’. Read more
Case study HIV
